A double-blind controlled clinical trial: Oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy

Epilepsy Research

Volumn 26, Issue 3, 1997, Pages 451-460

  Christe, Walter ^a   Krämer, Günter ^b   Vigonius, Ulf ^c   Pohlmann, Harald ^c   Steinhoff, Bernhard J ^d   Brodie, Martin J ^e   Moore, Alan ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c CIBA GEIGY LTD   (Switzerland)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e WESTERN INFIRMARY   (United Kingdom)

Author keywords

Long term measurement; Monotherapy; Oxcarbazepine; Sodium valproate

Indexed keywords

OXCARBAZEPINE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; FEMALE; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EPILEPSY, GENERALIZED; EPILEPSY, TONIC-CLONIC; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0343247768     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(96)01013-3     Document Type: Article

References (15)

1. Brodie, M.J., Established anticonvulsants and treatment of refractory epilepsy, Lancet, 336(8711) (1990) 350-354.
2. Brodie, M.J., Richens, A. and Yuen, A.W.C., Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy, Lancet 345(8948) (1995) 476-479.
3. Dam, M., Ekberg, R., Loyning, Y., Waltimo, O. and Jakobsen, K., A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy, Epilepsy Res., 3(1) (1989) 70-76.
4. Faigle, J.W. and Menge, G.P., Metabolic characteristics of oxcarbazepine (Trilpetal) and their beneficial implications for enzyme induction and drug interactions, Behav. Neurol., 3(1) (1990) 21-30.
5. Grant, S.M. and Faulds, D., Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders, Drugs, 43 (1992) 873-888.
6. Heller, A.J., Chesterman, P., Elwes, R.D.C., Crawford, P., Chadwick, D., Johnson. A.L. and Reynolds, E.H., Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial, J. Neurol. Neurosurg. Psychiatry, 58 (1995) 44-50.
7. Mattson, R.H., Cramer, J.A. and Collins, J.F., A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults, N. Engl. J. Med., 327(11) (1992) 765-771.
8. Reinikainen, K.J., Keraenen, T., Halonen, T., Komulainen, H. and Riekkinen, P.J., Comparison of oxcarbazepine and carbamazepine: a double-blind study, Epilepsy Res., 1(5) (1987) 284-289.
9. Richens, A., Davidson, D.L.W., Cartlidge, N.E.F. and Easter, D.J., A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy, J. Neurol. Neurosurg. Psychiatry, 57 (1994) 682-687.
10. Schmutz, M., Brugger, F., Gentsch, C., McLean, M.J. and Olpe, H.R., Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action, Epilepsia, 35(5) (1994) S47-S50.
11. Sidenwall, R., Epidemiology. In: M. Sillanpää, S.I. Johannessen, G. Blennow and M. Dam (Eds.), Paediatric Epilepsy, Wrightson Biomedical Publishing Ltd., Petersfield, UK, 1990, pp. 1-8.
12. Smith, D.B., Mattson, R.H., Cramer, J.A., Collins, J.F., Novelly, R.A., Craft, B. and the Veterans Administration Epilepsy Cooperative Study Group, Results of a nationwide veterans administration cooperative study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone, Epilepsia, 28(3) (1987) S50-58.
13. The Commission on Classification and Terminology of the International League Against Epilepsy, Proposal for revised clinical and electro- encephalographic classification of epileptic seizures. Epilepsia, 22(4) (1981) 489-501.
14. Trileptal Summary of Product Characteristics, Ciba-Geigy, Basel, March 24, 1993.
15. Van Amelsvoort, T., Bakshi, R., Devaux, C.B. and Schwabe, S., Hyponatremia associated with carbamazepine and oxcarbamazepine therapy: a review, Epilepsia, 35(1) (1994) 181-188.